Membrane associated proteins, RWD domain-containing Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005844 | polysome | 3 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:1990904 | ribonucleoprotein complex | 2 | 1 |
Related structures:
AlphaFold database: A0A3Q8IA02
Term | Name | Level | Count |
---|---|---|---|
GO:0002181 | cytoplasmic translation | 5 | 1 |
GO:0006412 | translation | 4 | 1 |
GO:0006518 | peptide metabolic process | 4 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009059 | macromolecule biosynthetic process | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034645 | obsolete cellular macromolecule biosynthetic process | 4 | 1 |
GO:0043043 | peptide biosynthetic process | 5 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043603 | amide metabolic process | 3 | 1 |
GO:0043604 | amide biosynthetic process | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 123 | 125 | PF00675 | 0.577 |
CLV_NRD_NRD_1 | 160 | 162 | PF00675 | 0.562 |
CLV_NRD_NRD_1 | 74 | 76 | PF00675 | 0.236 |
CLV_PCSK_KEX2_1 | 123 | 125 | PF00082 | 0.524 |
CLV_PCSK_KEX2_1 | 134 | 136 | PF00082 | 0.666 |
CLV_PCSK_KEX2_1 | 74 | 76 | PF00082 | 0.236 |
CLV_PCSK_PC1ET2_1 | 134 | 136 | PF00082 | 0.666 |
CLV_PCSK_SKI1_1 | 153 | 157 | PF00082 | 0.512 |
CLV_PCSK_SKI1_1 | 177 | 181 | PF00082 | 0.630 |
DOC_CYCLIN_RxL_1 | 150 | 160 | PF00134 | 0.538 |
DOC_MAPK_gen_1 | 171 | 181 | PF00069 | 0.688 |
DOC_PP2B_PxIxI_1 | 142 | 148 | PF00149 | 0.609 |
DOC_PP4_MxPP_1 | 1 | 4 | PF00568 | 0.616 |
DOC_USP7_UBL2_3 | 176 | 180 | PF12436 | 0.541 |
LIG_14-3-3_CanoR_1 | 24 | 32 | PF00244 | 0.501 |
LIG_14-3-3_CanoR_1 | 47 | 53 | PF00244 | 0.482 |
LIG_CaM_NSCaTE_8 | 192 | 199 | PF13499 | 0.578 |
LIG_deltaCOP1_diTrp_1 | 200 | 204 | PF00928 | 0.548 |
LIG_FHA_1 | 134 | 140 | PF00498 | 0.603 |
LIG_FHA_1 | 142 | 148 | PF00498 | 0.536 |
LIG_FHA_1 | 150 | 156 | PF00498 | 0.440 |
LIG_FHA_1 | 80 | 86 | PF00498 | 0.552 |
LIG_FHA_2 | 37 | 43 | PF00498 | 0.453 |
LIG_FHA_2 | 86 | 92 | PF00498 | 0.519 |
LIG_LIR_Gen_1 | 198 | 208 | PF02991 | 0.558 |
LIG_LIR_Gen_1 | 20 | 30 | PF02991 | 0.501 |
LIG_LIR_Nem_3 | 198 | 204 | PF02991 | 0.544 |
LIG_LIR_Nem_3 | 20 | 25 | PF02991 | 0.501 |
LIG_PTB_Apo_2 | 212 | 219 | PF02174 | 0.622 |
LIG_Rb_pABgroove_1 | 13 | 21 | PF01858 | 0.467 |
LIG_SH2_STAT5 | 32 | 35 | PF00017 | 0.561 |
LIG_SUMO_SIM_anti_2 | 97 | 103 | PF11976 | 0.445 |
LIG_SUMO_SIM_par_1 | 63 | 68 | PF11976 | 0.523 |
LIG_TRAF2_1 | 112 | 115 | PF00917 | 0.645 |
LIG_TRAF2_1 | 138 | 141 | PF00917 | 0.701 |
LIG_TRAF2_1 | 53 | 56 | PF00917 | 0.501 |
LIG_TRAF2_1 | 88 | 91 | PF00917 | 0.520 |
LIG_WW_1 | 29 | 32 | PF00397 | 0.467 |
MOD_CK1_1 | 184 | 190 | PF00069 | 0.579 |
MOD_CK1_1 | 195 | 201 | PF00069 | 0.598 |
MOD_CK2_1 | 36 | 42 | PF00069 | 0.507 |
MOD_CK2_1 | 84 | 90 | PF00069 | 0.531 |
MOD_GlcNHglycan | 181 | 184 | PF01048 | 0.598 |
MOD_GlcNHglycan | 186 | 189 | PF01048 | 0.542 |
MOD_GlcNHglycan | 197 | 200 | PF01048 | 0.471 |
MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.354 |
MOD_GSK3_1 | 28 | 35 | PF00069 | 0.475 |
MOD_NEK2_2 | 192 | 197 | PF00069 | 0.543 |
MOD_PIKK_1 | 36 | 42 | PF00454 | 0.501 |
MOD_PKA_2 | 23 | 29 | PF00069 | 0.501 |
MOD_Plk_1 | 192 | 198 | PF00069 | 0.544 |
MOD_Plk_2-3 | 217 | 223 | PF00069 | 0.611 |
MOD_Plk_2-3 | 23 | 29 | PF00069 | 0.529 |
MOD_Plk_4 | 94 | 100 | PF00069 | 0.462 |
MOD_SUMO_rev_2 | 110 | 119 | PF00179 | 0.530 |
MOD_SUMO_rev_2 | 173 | 179 | PF00179 | 0.522 |
TRG_DiLeu_BaEn_1 | 117 | 122 | PF01217 | 0.641 |
TRG_ENDOCYTIC_2 | 22 | 25 | PF00928 | 0.483 |
TRG_ER_diArg_1 | 122 | 124 | PF00400 | 0.619 |
TRG_ER_diArg_1 | 74 | 76 | PF00400 | 0.436 |
TRG_Pf-PMV_PEXEL_1 | 153 | 157 | PF00026 | 0.516 |
TRG_Pf-PMV_PEXEL_1 | 189 | 193 | PF00026 | 0.513 |
TRG_Pf-PMV_PEXEL_1 | 222 | 226 | PF00026 | 0.676 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ILT1 | Leptomonas seymouri | 76% | 100% |
A0A0S4IZT9 | Bodo saltans | 50% | 97% |
A0A1X0NWI2 | Trypanosomatidae | 58% | 97% |
A0A422NCD6 | Trypanosoma rangeli | 51% | 100% |
A4HYQ7 | Leishmania infantum | 100% | 100% |
C9ZI71 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 49% | 100% |
E9AIB1 | Leishmania braziliensis | 85% | 100% |
E9AUJ8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
Q4QCY6 | Leishmania major | 95% | 100% |
Q99ND9 | Rattus norvegicus | 30% | 95% |
Q9CQK7 | Mus musculus | 29% | 95% |
Q9H446 | Homo sapiens | 30% | 95% |